Online Evaluation of BlinkLab's Digital Assessments for Autism
This study is looking at how well a smartphone app called BlinkLab Dx1 can help identify autism in children. BlinkLab Dx1 uses video-watching to record a child's responses, like how they react to sounds or move. We want to see if these responses, measured by the app, match up with a child's existing autism diagnosis. Children aged 2 to 11 who have had a neurodevelopmental assessment for autism in the past 12 months can participate. The study aims to see how accurate BlinkLab Dx1 is at identifying autism (sensitivity and specificity) compared to a doctor's diagnosis. The study is currently unclear on its recruitment status and plans to enroll 1000 participants.
- Study design
- This is an observational study involving 1000 planned participants. It uses a hybrid approach, collecting new data with the BlinkLab Dx1 app and comparing it to past diagnostic assessments.
- What's involved
- Your child will complete two short, video-based sessions using the BlinkLab Dx1 app on a smartphone. You, as the primary caregiver, will also answer a short questionnaire in the app.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints (sensitivity and specificity of BlinkLab Dx1) are measured at baseline, which includes the index test completed during enrollment and the reference standard diagnosis from assessments within the prior 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism
At a glance
Conditions
NCT07590973
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Remote study conducted nationwide; all participation occurs via smartphone app at home.
Princeton, New Jerseystudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Sensitivity of BlinkLab Dx1Baseline (including index test completed during the enrollment period and reference standard diagnosis from assessments conducted within 12 months prior to enrollment)
Sensitivity of BlinkLab Dx1, defined as the proportion of participants with a positive clinical reference standard diagnosis of autism who are correctly identified as positive by the index test.
- Specificity of BlinkLab Dx1Baseline (including index test completed during the enrollment period and reference standard diagnosis from assessments conducted within 12 months prior to enrollment)
Specificity of the BlinkLab Dx1 algorithm, defined as the proportion of participants without a clinical reference standard diagnosis of autism who are correctly identified as negative by the index test.